94 related articles for article (PubMed ID: 11849474)
1. Can angiotensin II be used for renoprotection?
de Zeeuw D
Kidney Int; 2002 Mar; 61(3):1176-7. PubMed ID: 11849474
[No Abstract] [Full Text] [Related]
2. Effects of angiotensin on the function and metabolism of the ischemic kidney.
P2AU6SESCU E; Beroniade V; Rădulescu C; Cărnaru S; Lugojan R; Osiescu J
Arch Int Pharmacodyn Ther; 1970 Jul; 186(1):28-38. PubMed ID: 4319659
[No Abstract] [Full Text] [Related]
3. Renal ischemia modified by an angiotensin antagonist.
Uehling D; Heber D; Goodfriend TL
Invest Urol; 1974 Mar; 11(5):345-6. PubMed ID: 4361088
[No Abstract] [Full Text] [Related]
4. Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2.
Hayashi K; Sasamura H; Ishiguro K; Sakamaki Y; Azegami T; Itoh H
Kidney Int; 2010 Jul; 78(1):69-78. PubMed ID: 20375993
[TBL] [Abstract][Full Text] [Related]
5. [Effect of angiotensin II on autotransplanted kidney].
Ruso A; Cirino E; Ingegneros L; Giovinetto A; Ippolito O
Minerva Nefrol; 1973; 20(1):18-22. PubMed ID: 4361191
[No Abstract] [Full Text] [Related]
6. [Effect of angiotensin II on autotransplanted kidney].
Russo A; Cirino E; Ingegneros L; Giovinetto A; Ippolito O
Mod Hosp; 1973; 20(1):18-22. PubMed ID: 4353681
[No Abstract] [Full Text] [Related]
7. [Renin-angiotensin system in kidney physiology and pathology].
Łapiński R
Postepy Hig Med Dosw; 2000; 54(5):639-56. PubMed ID: 11146891
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation.
Carvajal G; Rodríguez-Vita J; Rodrigues-Díez R; Sánchez-López E; Rupérez M; Cartier C; Esteban V; Ortiz A; Egido J; Mezzano SA; Ruiz-Ortega M
Kidney Int; 2008 Sep; 74(5):585-95. PubMed ID: 18509316
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II: a pivotal factor in the progression of renal diseases.
Wolf G
Nephrol Dial Transplant; 1999; 14 Suppl 1():42-4. PubMed ID: 10048448
[No Abstract] [Full Text] [Related]
10. [Changes in kidney function values under angiotensin effect in various kidney diseases].
Pogglitsch H; Giessauf W; Feldner H; Stöckl G; Oser W
Wien Klin Wochenschr; 1969 Mar; 81(10):170-5. PubMed ID: 4332262
[No Abstract] [Full Text] [Related]
11. Reversal of renal disease: is it enough to inhibit the action of angiotensin II?
Dussaule JC; Chatziantoniou C
Cell Death Differ; 2007 Jul; 14(7):1343-9. PubMed ID: 17396129
[TBL] [Abstract][Full Text] [Related]
12. Some observations on the pathogenesis of Bartter's syndrome.
Modlinger RS; Nicolis GL; Krakoff LR; Gabrilove JL
N Engl J Med; 1973 Nov; 289(19):1022-4. PubMed ID: 4355057
[No Abstract] [Full Text] [Related]
13. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation.
Fanelli C; Fernandes BH; Machado FG; Okabe C; Malheiros DM; Fujihara CK; Zatz R
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F580-7. PubMed ID: 21653629
[TBL] [Abstract][Full Text] [Related]
14. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
15. [Angiotensin-converting enzyme inhibitors: effects on renal physiology and applications in hypertension and renal disease].
Cofán F; Romero R
Rev Clin Esp; 1993 Jan; 192(1):31-8. PubMed ID: 8465029
[No Abstract] [Full Text] [Related]
16. The renin-angiotensin-aldosterone system in parenchymal kidney disease.
Maxwell MH; Weidmann P
Adv Nephrol Necker Hosp; 1975; 5():301-32. PubMed ID: 171933
[No Abstract] [Full Text] [Related]
17. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
Patel TV; Williams GH; Fisher ND
J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010
[TBL] [Abstract][Full Text] [Related]
18. Effect of Asp1-beta-amide-Val5-angiotensin II, Sar1-lle5-angiotensin II and (N,N-dimethyl) Gly1-lle5-angiotensin II on isolated perfused rabbit kidney.
Ercan ZS; Türker RK; Bökesoy TA
Arch Int Pharmacodyn Ther; 1974 Oct; 211(2):237-46. PubMed ID: 4376677
[No Abstract] [Full Text] [Related]
19. The restoration of kidney mitochondria function by inhibition of angiotensin-II production in rats with acute adriamycin-induced nephrotoxicity.
Taskin E; Ozdogan K; Kunduz Kindap E; Dursun N
Ren Fail; 2014 May; 36(4):606-12. PubMed ID: 24502693
[TBL] [Abstract][Full Text] [Related]
20. [On hemodynamic control of renal function].
Agnoli GC; Cariani A; Farné F; Gritti FM; Montini T
Boll Soc Ital Cardiol; 1970; 15(6):514-38. PubMed ID: 4325449
[No Abstract] [Full Text] [Related]
[Next] [New Search]
